Abstract
A series of 4-(4-hydroxyphenyl)-6-phenylpyrimidin-2(1 H)-ones were identified by HTS as inhibitors of CDC7. Molecular modeling and medicinal chemistry techniques were employed to explore the SAR for this series with a focus on removing potential metabolic liabilities and improving cellular potency.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have